May 28, 2026 04:01PM
Feb 9, 2026 09:46AM
Sep 2, 2025 09:33PM
May 15, 2025 10:47AM
Jan 27, 2025 09:21AM
Jan 27, 2025 09:21AM
Jan 27, 2025 09:20AM Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
Oct 30, 2024 04:37PM
Sep 12, 2024 07:30AM
Sep 12, 2024 07:30AM
Jul 26, 2024 12:18PM
May 22, 2024 07:31AM
May 22, 2024 07:30AM
Jul 28, 2023 07:07AM Biogen (BIIB) to Acquire Reata Pharmaceuticals (RETA) for $172.50/Share, Approximately $7.3 Billion
Jul 28, 2023 07:05AM
Jul 12, 2023 07:03AM
Jul 7, 2023 07:48AM
Jun 1, 2023 12:55PM
Feb 13, 2023 07:34AM
Jan 9, 2023 07:03AM
Nov 30, 2022 08:52AM Analysts impressed by Biogen (BIIB) after full data on Alzheimer's drug Lecanemab
Oct 26, 2022 03:54PM
Oct 26, 2022 03:41PM
Oct 26, 2022 09:06AM
Apr 7, 2022 06:03PM
Jan 13, 2022 03:34PM
Jan 13, 2022 02:22PM
Dec 6, 2021 05:42AM UPDATE: Goldman Sachs Starts Biogen (BIIB) at Neutral
Nov 27, 2020 07:31AM
Nov 27, 2020 07:30AM
Nov 27, 2020 07:30AM
Nov 27, 2020 07:30AM
Aug 14, 2020 04:11PM
Jul 27, 2020 09:30AM
May 15, 2020 04:22PM Buffett's Berkshire 13F Shows Reduced Stake in Goldman Sachs (GS), Liquidated Travelers (TRV), Phillips 66 (PSX) (more...)
May 4, 2020 08:02PM
Apr 27, 2020 04:06PM
Apr 27, 2020 04:06PM
Apr 22, 2020 02:32PM
Apr 2, 2020 03:38PM
Mar 24, 2020 08:30AM
Mar 24, 2020 08:15AM S&P 500 buybacks up 3.2% in Q4 2019; Full Year 2019 down 9.6% from record 2018, as companies brace for a more volatile 2020
Feb 14, 2020 04:19PM
Oct 11, 2019 01:00PM
Oct 10, 2019 07:58PM
Mar 21, 2019 10:33AM
Mar 21, 2019 09:26AM
Jun 18, 2018 09:30AM
Apr 25, 2018 04:39AM UPDATE: Goldman Sachs Downgrades Biogen (BIIB) to Buy
Apr 18, 2018 12:25PM

189,921 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All